• SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation 05.11.2026

• Robust T and B cell activation is associated with rapid clearance of infectious SARS-CoV-2 05.11.2026

• COVID‑19 nucleic acid vaccines, their many virtues, some deficiencies and unsuspected novel features. A reflection after pandemic resolution and present endemic SARS-CoV-2 circulation 05.11.2026

• Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania 05.11.2026

• State Capture and Institutional Recovery at SARS:
  Implications for Financial Crime Enforcement in South Africa 05.11.2026

• Genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) sequences across six pandemic waves in Pakistan 05.11.2026

• Evaluation and Estimation of Epidemic Trajectories for SARS-CoV-2 from Clinical and Wastewater Data in Gauteng Province, South Africa 05.11.2026

• Bloodstream Isolation of Klebsiella Pneumoniae in Adults Hospitalized with SARS-CoV-2 During the Omicron BA.5 Wave:
  A Retrospective Cohort Study 05.11.2026

• Lecciones aprendidas durante la pandemia de SARS-COV-2 y preparación de nuevas vacunas frente a amenazas epidémicas/pandémicas 05.11.2026

• Neurofunctional Outcomes After Pediatric SARS-CoV-2 Infection and Acute Interferon-Related Gene Expression:
  An Exploratory Observational Pilot Study 05.11.2026

• SARS-CoV-2 infection and genomic diversity in Quilombola communities during Brazil’s gamma VOC wave 05.11.2026

• Identification of small-molecule inhibitors of the SARS-CoV-2 RBD–ACE2 interaction by structure- and affinity-based screening 05.11.2026

• Clinical Phenotype and Outcomes of Multisystem Inflammatory Syndrome in Children According to SARS‐CoV‐2 Laboratory Status During 2020–2021:
  A Retrospective Observational Study 05.11.2026

• SARS-CoV-2 and the Gut:
  From Viral Persistence to Post-Infectious Gut–Brain Disorders 05.11.2026

• Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease 05.11.2026

• Small Molecules Targeting SARS-CoV-2 Nucleocapsid Reveal a Conserved RNA-Binding Vulnerability Across Human Coronaviruses 05.11.2026

• OP–185 Prevalence of acute rheumatic fever in the 2019 sars-cov-2 pandemic 05.11.2026

• OP–207 Long-term neurodevelopmental effects of in-utero SARS-CoV-2 exposure 05.11.2026

• VaccineScout:
  A Computational Framework for Guiding the Composition and Valency of SARS-CoV-2 Vaccine Updates 05.11.2026

• Reproducible cluster headache remission following SARS-CoV-2 mRNA vaccination:
  a case report 05.11.2026

• Documented SARS-CoV-2 infection and risk of neurodegenerative disease diagnosis:
  a target trial emulation across three real-world cohorts 05.11.2026

• PABbind:
  A Hierarchical Geometric Framework for Mutation-Involved Antigen-Antibody Interaction Prediction and SARS-CoV-2 Immune Escape Assessment 05.11.2026

• Inter-jurisdictional Differences and Coordination Pathways in the Classification and Grading of Power Data:
  A Comparative Study across the Taiwan Strait and between Hong Kong and Macao SARs 05.11.2026

• Inter-Jurisdictional Regulatory Coordination on Cross-Border Data Flows in AIoT-Enabled Smart Grids:
  A Comparative Study Across the Taiwan Strait and between Hong Kong and Macao SARs 05.11.2026

• Low transmission of SARS-CoV-2 in households in Sahelian area:
  when do we need to isolate positive patients? 05.11.2026

• Recent positive psychosocial experiences are linked to SARS-CoV-2 IgG immune memory in adults exposed to adverse childhood experiences 05.11.2026

• Pooled testing for SARS-CoV-2 surveillance in schools:
  evaluation of transmission control, testing resources, and educational disruption 05.11.2026

• Randomised controlled phase I trial of a SARS ‐ CoV ‐2 monoclonal antibody 05.11.2026

• PABbind:
  A Hierarchical Geometric Framework for Mutation-Involved Antigen−Antibody Interaction Prediction and SARS-CoV-2 Immune Escape Assessment 05.11.2026

• Pooled testing for SARS-CoV-2 surveillance in schools:
  evaluation of transmission control, testing resources, and educational disruption. 04.11.2026

• Assessment of coronavirus disease 2019 mRNA vaccine response in kidney transplant recipients. 04.11.2026

• Experiences of individually tailored physical exercise in COVID-19-induced postural orthostatic tachycardia syndrome:
  A qualitative content analysis. 04.11.2026

• Introducing SARS-CoV-2 wastewater surveillance in Lebanon. 04.11.2026

• Design and Numerical Investigation of Graphene-Ribbon-Integrated Terahertz Metasurface Biosensor for Refractive Index Based SARS-CoV-2 Detection 04.11.2026

• Preliminary evaluation of qualitative RT-PCR and indirect immunofluorescence for SARS-CoV-2 detection in nasopharyngeal swabs samples 04.11.2026

• Pediatric Immunoglobulin A (IgA) Vasculitis Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2):
  Clinical Characteristics, Renal Involvement, and Short-Term Outcomes 04.11.2026

• Effect of Intranasal Administration of SARS-CoV-2 ORF8 Accessory Protein on the First Line of Antioxidant Defense in Male BALB/c Mice 04.11.2026

• Environmental circulation of airborne SARS-CoV-2 particles in intensive care rooms 04.11.2026

• Integrated Molecular and Serological Epizootic Monitoring of SARS-CoV-2 and Influenza A Virus in Animals in Kazakhstan 04.11.2026

• Introducing SARS-CoV-2 wastewater surveillance in Lebanon 04.11.2026

• Timing dependent associations of acute phase laboratory and antibody parameters with post-acute sequelae of SARS-CoV-2 infection in unvaccinated individuals 04.11.2026

• Результаты клинического испытания рекомбинантной вакцины против Омикрон-Дельта штаммов SARS-CoV-2 04.11.2026

• Serologic and clinical correlates of within-host SARS-CoV-2 genetic diversity in a large acute-infection cohort 04.11.2026

• Honeybee (Apis mellifera) venom and its bioactive peptides tertiapin and apamin modulate the proteome of SARS-CoV-2-infected cells. 03.11.2026

• Living with SARS-CoV-2:
  A 6-year reflection on the pandemic's ongoing impact and future implications. 03.11.2026

• Relationship between Profile, Quality of Life and Burden of Older People With Dementia's Caregivers during the COVID-19 Pandemic. 03.11.2026

• Bovine-Associated Viruses at the Human-Animal Interface:
  Zoonotic Risks, Spillover Dynamics, and One Health Implications. 03.11.2026

• Changes in self-reported Long COVID in different variant-dominant phases of the SARS-CoV-2 pandemic:
  the influence of vaccination on a diverse Israeli cohort study. 03.11.2026

• Long COVID prevalence among U.S. adults:
  A state-level ecological analysis of associations with SARS-CoV-2 incidence, COVID-19 hospitalization rates, COVID-19 vaccine coverage, and multimorbidity. 03.11.2026

• eNAMPT is a plasma biomarker of COVID-19 severity and ARDS progression linked to increased immune effector cell expression. 03.11.2026

• Epigenetic aging during the COVID-19 pandemic:
  A prospective longitudinal study with prepandemic baseline data in children, adolescents, and adults. 03.11.2026

• Non-covalent inhibitors targeting SARS-CoV-2 3CLpro:
  structural insights and developmental landscape. 03.11.2026

• Therapeutic opportunities of marine-derived bioactive compounds against SARS-CoV-2 and other enveloped viruses. 03.11.2026

• In vitro antioxidant, anti-inflammatory, antifungal, and anti-HCoV-229E activities of Jatropha integerrima leaf and stem bark extract and in vivo evaluation of its intravenous SNEDDS in a mouse model. 03.11.2026

• Multi-virus Wastewater Surveillance in Heterogeneous Urban-Sewage Systems:
  Comparative Insights From Sewage Treatment Plants and Open Drains. 03.11.2026

• Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1. 03.11.2026

• Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered spike localization and increased cell-to-cell transmission. 03.11.2026

• Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity. 03.11.2026

• Assessing the Age-Specific Seroepidemiology of Varicella-Zoster Virus in Korea in the Post-COVID-19 Era Using an Acetone-Fixed Cell FAMA Assay. 02.11.2026

• Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026

• Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026

• Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival. 01.11.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026

• First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System:
  An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. 30.10.2026

• Catalyst-free synthesis of imidazol-4-ylphosphonates from N-arylamidines and diisopropyl (chloroethynyl)phosphonate. 28.10.2026

• Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026

• SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026

• Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026

• The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026

• Herpesvirus reactivation in COVID-19:
  clinical evidence, mechanistic insights, and research gaps. 20.10.2026

• Depression, anxiety, and stress at different time frames in relation to COVID-19 disease course:
  a Flemish observational study. 20.10.2026

• Analysis of multiplex pathogen sentinel surveillance results of SARS-CoV-2 and influenza virus in Sichuan Province, 2024-2026. 20.10.2026

• Single-cell profiling of dysfunctional NK cells in COVID-19:
  from immunization to acute infection and beyond. 20.10.2026

• Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026

• The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026

• Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026

• Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026

• Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026

• SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026

• SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026

• The WHO interim Medical Countermeasures Network for public health emergencies. 08.10.2026

• Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026

• Social inequalities in SARS-CoV-2 infection in France:
  An intersectional analysis 01.10.2026

• Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:
  Quanta Profiles and Infection Control. 01.10.2026

• Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026

• The other immune landscape of SARS-CoV-2 evolution. 28.09.2026

• Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026

• Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026

• Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026

• Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026

• Laboratory adaptation of the SARS-CoV-2 Delta variant in Vero E6 cells enhances in vitro growth but attenuates human TMPRSS2-dependent fitness, pathogenicity, and transmission. 07.09.2026

• Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026

• A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026

• Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026

• Incidence of new-onset pulmonary fibrosis 4.5 years post SARS-CoV-2 infection in an academic urban medical center. 07.08.2026

• The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026

• Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026

• Prevalence of SARS-COV-2 infection, Relationship between SARS-CoV-2 and HIV among Sex Workers in Cotonou. 01.08.2026

• Exploration of Nirmatrelvir Derivatives as Optimized SARS-CoV-2 Antivirals. 01.08.2026

Quellen: PubMed, Europe PMC & CrossRef